ST景峰
No insider purchase over the last 90 days. The latest, by 周神东, was filed 12 Sept 2023.
This page follows insider dealings at CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. No insider at CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 12 September 2023.
Looking back to 2021, when coverage begins, insiders filed 1 purchase and 3 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
4 of 4 declarations
ST景峰 is a company in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in the development and production of pharmaceutical products.